跳至主要内容
临床试验/NL-OMON49754
NL-OMON49754已完成不适用

Trained immunity in bone marrow progenitors as driver of atherosclerosis in obesity. - TRIM in obesity

Radboud Universitair Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Participant in 300OB cohort, so all have a BMI> 27 and age >18 years
  • -Written informed consent
  • -4 weeks prior to inclusion stop cholesterol lowering drugs such as: statins

排除标准

  • -Inability to personally provide written informed consent (e.g. for linguistic
  • or mental reasons)
  • -Documented bleeding diathesis or thrombocytopenia <50 *10e9/L
  • -History of haematological malignant disease
  • -Current treatment for maligancy
  • -Acute or chronic infections at the time of participation
  • -Medical history of any disease associated with immune deficiency (either
  • congenital or acquired, including chemotherapy, chronic steroid use, organ
  • transplant)
  • -Clinically significant infections within 1 months prior to study entry
  • (defined as fever >38.5)
  • -Previous vaccination within 1 months prior to study entry
  • -Chronic use of anti-inflammatory drugs such as NSAIDs (acetylsalicylic acid
  • <100 mg/day excluded)

研究者

相似试验

Trained immunity in bone marrow progenitors as... | 临床试验